Virgo Public Relations
PR TipsPublished November 16, 20267 min read

Getting a Scientist or Founder Quoted: 8 Rules for 2027

By Kyle Porter, Executive Vice President & Managing Director.

Updated November 16, 2026

Follow on LinkedIn ↗
Getting a Scientist or Founder Quoted: 8 Rules for 2027
Key takeaway

How to get a scientist or founder quoted in the media: eight rules on plain language, evidence, embargoes, approvals and disclosure, with a 30 day plan.

To get a scientist or founder quoted in the media, translate the work into one plain-language point, back it with evidence a reporter can check, and clear every claim before it is said. Scientists add the research record. Founders add the customer and market view. This guide covers eight rules that apply to both, and it links to the general executive guide for the shared basics.

Updated November 15, 2026. Virgo PR publishes this guide and also sells PR services. This is communications guidance, not legal advice. Public company executives and anyone discussing unpublished data should clear quotes with counsel.

In short:

  • A quotable scientist explains why the finding matters in one or two plain sentences.
  • A quotable founder names a customer behavior, a number and a limit.
  • Both should show their record: papers, patents, filings or dated, correct predictions.
  • Approvals, embargoes and disclosure come before the pitch, not after.

Contents

How is getting a scientist or founder quoted different from an executive quote?

The difference is the standard of proof. A reporter will accept a general view from a chief executive more easily than a claim from a scientist or founder about a product or a result, because scientific and product claims can be wrong in ways that hurt readers. That raises the bar for evidence and wording, and it makes approvals more important.

The shared basics, such as choosing topics, building a quote bank and using request platforms, are covered in Virgo's guide to getting an executive quoted in major media. This guide covers only what changes for scientists and founders, so read both together.

Rule 1: What is the plain-language point?

The plain-language point is the single sentence a reader without your training could repeat. Reporters write for general audiences, so a quote full of technical terms is hard to use. Start with the result, then the reason it matters, then one detail.

  • Weak: a description of the mechanism with no consequence.
  • Strong: what changes for a patient, a customer or a cost, followed by one supporting fact.

Founders face the same test from the other side. A product description is not a point of view, while a clear statement of what customers are doing differently usually is.

Rule 2: What evidence backs the claim?

Evidence is anything a reporter can check without taking your word for it. For a scientist that means a published paper, a registered study, a dataset or a patent. For a founder it means a named customer who has approved the mention, a public filing or data the company is willing to publish with its method.

  • Link the primary source, not a press summary.
  • State the sample size or scope in one sentence.
  • Say what the evidence does not show.
  • Offer a second, independent expert who can comment.

Reporters often seek an outside view on technical claims, so naming a colleague who can speak independently makes you easier to quote, not harder.

Rule 3: What are the limits of the claim?

State the limits yourself, because a reporter who finds them first will trust you less. Early results, small samples and preliminary data should be described as that. Founders should separate what a product does today from what the roadmap promises. Overstating results invites correction and damages the credibility that gets you quoted again.

For biotech and medical device companies, the wording of safety and effectiveness claims has extra rules. Virgo's FDA communications guide and topline data releases guide show how announcements handle good, mixed and bad news.

Rule 4: Who clears the claims?

Name the approvers before any request arrives. Universities, hospitals, research institutes and funders often have communications offices that expect to review media contact. Companies need legal and, where relevant, regulatory review. Agree who signs off and how fast, so a compliant answer still arrives while a request is open.

  • Check your institution's media policy before you reply to a reporter.
  • Ask whether co-authors or sponsors need to be informed.
  • Get counsel to review any statement about unpublished data, financing or regulatory status.
  • Keep a record of what was approved and when.

Rule 5: How do embargoes and publication timing shape a quote?

Embargoes and publication timing decide when you can speak. Many journals set a time after which a paper may be covered, and reporters who receive a paper early agree to hold the story until then. Follow the journal's own policy and never discuss embargoed results outside the agreed window.

Preprints and conference abstracts are treated differently from peer-reviewed papers, and some reporters take extra care with unreviewed work. Say clearly what stage a result has reached. Virgo's medical congress PR guide walks through the steps from abstract to embargo.

Rule 6: How do reporters verify the source?

Reporters verify a source by searching the name, so the first results should confirm who you are and what you know. Keep one consistent bio, a current institutional or company page and a profile that matches. A scientist should link to a publication list, and a founder to a company page and past coverage.

  • Use the same title and affiliation everywhere.
  • Link papers, patents or filings from the bio.
  • Add a short press page with a photo and contact details.
  • Collect past quotes and bylines in one place.

The same consistency helps AI search tools describe you correctly, since those tools draw on the same public pages.

Rule 7: How fast should the answer be?

Answer within the hour when a request matches your topic and you have cleared the claim. Deadlines are short and the first qualified source often gets used. Speed comes from preparation: keep a short document with plain answers to the questions a reporter is most likely to ask, with sources and approvals already attached. Media training also helps, and Virgo's guide on preparing an executive for a media interview covers rehearsal and hard questions.

Rule 8: What must be disclosed?

Disclose anything that could change how a reader weighs your view. Reporters expect to know about funding sources, company ownership, advisory roles and stakes in the outcome. A founder commenting on their own market should say so, and a scientist commenting on a field where they hold equity should say that too. Clear disclosure protects the quote and the source.

Companies hiring outside help to find the right agency can compare options in Virgo's list of the best biotech and life sciences PR agencies.

What does a 30 day plan look like?

A first month should build credibility and start responding, not chase a single big placement. The plan below is working guidance and not a published standard.

  • Week 1: choose two topics, collect the primary sources and confirm who approves media contact.
  • Week 2: write plain answers to the ten likeliest questions per topic, with sources, and update the bio and profiles.
  • Week 3: answer matching reporter requests within the hour, using only cleared claims.
  • Week 4: send three tailored pitches with a news hook, then review which were used and why.

What mistakes keep scientists and founders out of stories?

  • Using jargon. A reporter cannot use a quote the reader will not understand.
  • Overclaiming. Early data presented as proof invites correction.
  • Skipping approvals. A quote withdrawn after publication does more harm than no quote.
  • Ignoring embargoes. Breaking one can end a relationship with a reporter.
  • Promoting the company. Reporters want an answer, not an advertisement.
  • Hiding conflicts. Undisclosed interests damage trust in the whole quote.

Frequently asked questions

How does a scientist get quoted in the media?

Pick a narrow topic, explain the finding in plain language, link the primary evidence and answer reporter requests quickly with approved claims. Consistency over several months matters more than any single placement.

How does a founder get quoted?

Offer a named customer behavior, one checkable number and a clear limit, and pitch a reporter a news hook tied to something they already cover.

Do I need my institution's permission?

Often yes. Many universities, hospitals and funders have media policies, so check before replying and ask who must approve.

Can I talk about unpublished data?

Be cautious. Unpublished or embargoed results can create legal, journal and financing problems, so have counsel and your institution review first.

Do I need a PR agency?

No. You can use request platforms and direct pitching alone. An agency adds reporter relationships, speed and a steady pitch calendar, and its value depends on how much time you have.

What if a reporter gets the science wrong?

Ask politely for a correction with the exact wording and a link to the source. Most outlets fix factual errors when asked promptly and courteously.

How do I know if it is working?

Track quotes used, outlets, topics and replies from reporters in one log, and review it each quarter. Repeat requests from the same reporters are a stronger signal than a single placement.

Editorial disclosure

Virgo PR publishes this guide and also sells PR services. The guidance reflects common media practice and Virgo PR's own experience, no study is cited for its timing, and results vary by field, outlet and effort. This guide is general information, not legal advice.

Follow us

LinkedIn
Contact

Let's make
noise.

Send a note. The senior team reads every inbound, no junior filter, no auto-pitch.

Phone

Phone

212.584.4289
Social

Social

24-hour response, every weekday
Confidential, NDAs available on request
Retainers from around $10,000 per month, 4 month minimum

Start the conversation